A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

RECRUITING

National Taiwan University Hospital /ID# 267666, Taipei City

RECRUITING

Taipei Veterans General Hospital /ID# 267664, Taipei

RECRUITING

Linkou Chang Gung Memorial Hospital /ID# 267668, Taoyuan

RECRUITING

China Medical University Hospital /ID# 267667, Taichung

RECRUITING

National Cheng Kung University Hospital /ID# 267669, Tainan City

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 267672, Kaohsiung City

RECRUITING

Hattiesburg Clinic /ID# 268572, Hattiesburg

RECRUITING

Millennium Research & Clinical Development /ID# 268540, Houston

RECRUITING

UCLA - Santa Monica /ID# 270024, Santa Monica

RECRUITING

City of Hope National Medical Center /ID# 268690, Duarte

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 267753, Jerusalem

RECRUITING

City of Hope - Orange County Lennar Foundation Cancer Center /ID# 272630, Irvine

RECRUITING

Beijing Cancer Hospital /ID# 268455, Beijing

RECRUITING

The first Affiliated Hospital, Zhejiang University School of Medicine /ID# 268782, Hangzhou

RECRUITING

Union Hospital - Tongji Medical College /ID# 268796, Wuhan

RECRUITING

Tel Aviv Sourasky Medical Center /ID# 267755, Tel Aviv

RECRUITING

Soroka Medical Center /ID# 268301, Beersheba

RECRUITING

Shaare Zedek Medical Center /ID# 267752, Jerusalem

RECRUITING

Aichi Cancer Center /ID# 268124, Nagoya

RECRUITING

National Cancer Center Hospital East /ID# 268083, Kashiwa-shi

RECRUITING

Shizuoka Cancer Center /ID# 268123, Sunto-gun

RECRUITING

National Cancer Center Hospital /ID# 268648, Chuo-Ku

RECRUITING

The Cancer Institute Hospital Of JFCR /ID# 268656, Koto-ku

RECRUITING

Pan American Center for Oncology Trials /ID# 268833, Rio Piedras